Director, Oncology Clinical Development Lead - Munich, Deutschland - ITM Isotope Technologies Munich SE
Beschreibung
Your Role:
- Member of the medical team, with key role of providing clinical oncology strategy to the entire development pipeline and acting as a clinical development lead for assigned compounds during phase 1
- Develop and lead the clinical development plans for the assigned compounds, provide oncology expertise and strategic contribution to the entire pipeline
- Interact closely with other (core team) functions e.g. preclinical development, medical affairs, regulatory affairs, pharmacovigilance, clinical operations in developing compounds through the different clinical development phases and phase transitions
- Lead the design of clinical study protocols, the execution of the clinical trials and the writing of clinical study reports, according to current international regulations and guidelines
- Support strategic development of the company with the identification and assessment of new molecular entity opportunities, with participation in due diligence activities
- Lead the organization and running of national and/or international expert consultations and multidisciplinary advisory boards
- Contribute to the publications related to clinical data and presentation of results at internal and external meetings
- Ensure integrity of data and interpretation of clinical study results
- Lead the development and medicoscientific interactions with regulatory authorities for assigned development projects (e.g. Investigator Brochures, regulatory dossiers, scientific advice meetings, answering List of Questions)
What we are looking for:
- Doctor of medicine, preferably with a board accreditation in oncology
- Solid experience (track record of > 5 years in the industry) in oncology clinical development of new chemical entities (early and late clinical stage development, development of the clinical strategy, setting up a clinical development plan and target product profiles in collaboration with other functions), experience in radiotheranostic development would be a distinct advantage
- Solid background in the development of clinical study protocols and study reports including sound knowledge of clinical development methodology and study designs
- Strategic mindset, with previous experience in due diligence activities
- Sound knowledge of ICH-GCP and other relevant regulations/guidelines
- Experience in interacting with regulatory authorities
- Demonstrated expertise in ability to lead complex medical and scientific discussions and synthesize and communicate information clearly
- Demonstrated team spirit and leadership experience, with ability to work in a mediumsize company with a matrix environment
What we offer:
- A modern workplace and exciting opportunities in an evolving and fast growing company
- Challenging and varied projects in interdisciplinary, multicultural and highly professional teams
- A collegial corporate culture and short communication channels
- Flexible working hours with an attractive salary package and diverse corporate benefits
- Flexible home office possibilities
Only together we can contribute to significantly improving the outcome and quality of life of cancer patients worldwide and to giving better answers than "maybe".
Then send us your detailed CV including earliest start date and salary expectations. The position is intended for the ITM Oncologics GmbH, a company of the ITM group. Applications are accepted either in German or English language.
Mehr Jobs von ITM Isotope Technologies Munich SE
-
Projektmanager für pharmazeutische Anlagen
Garching bei München, Deutschland - vor 13 Stunden
-
Global Automation Engineer
Garching bei München, Deutschland - vor 3 Wochen
-
Medical Administrator
Munich, Deutschland - vor 3 Wochen
-
CTA / PTA / Chemielaborant in der Reagenzienvorbereitung (f/m/d)
Garching bei München # Neufahrn bei Freising, Deutschland - vor 13 Stunden
-
Auftragssachbearbeiter (F/m/d)
Munich, Deutschland - vor 1 Woche
-
Procurement Project Specialist
Garching bei München, Deutschland - vor 3 Wochen